Roche Pharma India Unveils Clinical Trial Excellence Project to Enhance Research Capacities

The prime objective of this alliance is to support government hospitals in evolving into Centers of Excellence for clinical research, thereby enhancing their role and influence in the healthcare landscape.

Roche Pharma India, a biopharmaceutical company, has launched its Clinical Trial Excellence project in India.

The company has embarked on this venture in collaboration with the Kalyan Singh Super Specialty Cancer Institute (KSSSCI) based in Lucknow, Uttar Pradesh.

KSSSCI, a cancer center backed by the Uttar Pradesh government and boasting 750 beds, actively engages in cancer research and education.

The prime objective of this alliance is to support government hospitals in evolving into Centers of Excellence for clinical research, thereby enhancing their role and influence in the healthcare landscape.

Commenting on the same, V Simpson Emmanuel, MD & CEO of Roche Pharma India, said, "This collaboration positions us as knowledge partners, enabling the integration of cutting-edge clinical and digital skills. Our collective initiative aims to propel the healthcare sector forward while enhancing healthcare throughout India.”

He added, “This initiative is in line with the government's recently launched Research and Development (R&D) policy, aiming to bolster healthcare infrastructure while enhancing the skills and capabilities of healthcare professionals. With enhanced skills and capabilities, India will be better positioned to conduct clinical trials for diseases prevalent in its population and improve access to medicines."

In the program's initial phase, Roche Pharma India aims to collaborate with 10 government hospitals, keeping an objective to enhance clinical research capabilities by bolstering their existing infrastructure to conduct clinical trials according to global standards.

This augmentation will include essential facets such as training the research teams, refining processes, and embracing digital solutions for streamlined dossier submission and review by Ethics Committees.

These efforts collectively pave the way for conducting high-quality clinical research, prioritising innovative treatments, and ensuring patient safety.

Founded in 1896, Roche is a global biopharmaceutical company that continues to advance science for the betterment of healthcare through its pharmaceutical and diagnostics divisions.

The company boasts differentiated medicines in vital fields such as oncology, immunology, infectious diseases, ophthalmology, and the central nervous system.

Notably, 30 of Roche's medicines are included in the World Health Organization Model Lists of Essential Medicines, highlighting the company's vital contributions to essential medical solutions.

There have been a lot of advancements happening in the realm of cancer care. In September, the Indian Cancer Society joined forces with Roche Pharma India to unveil a mobile application called 'Rise against Cancer.'

This app, available on Android and iOS platforms and offered in multiple languages, is a comprehensive resource providing vital information and support to individuals and families grappling with cancer.

In a related initiative, Fujifilm India has deployed 125 state-of-the-art AMULET Innovality digital mammography machines nationwide. This move aims to promote early detection of breast cancer and equip healthcare practitioners with advanced tools to enhance patient care.